5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer. (Record no. 1699659)

MARC details
000 -LEADER
fixed length control field 01481 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250511201004.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199006s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0277-3732
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/00000421-199006000-00005
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Lopez, M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19900629
245 00 - TITLE STATEMENT
Title 5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. American journal of clinical oncology
Date of publication, distribution, etc. Jun 1990
300 ## - PHYSICAL DESCRIPTION
Extent 204-7 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adenocarcinoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carmustine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Epirubicin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fluorouracil
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphatic Metastasis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Palliative Care
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Stomach Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Analysis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Natali, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Di Lauro, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tonini, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Carpano, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vici, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Conti, E M
773 0# - HOST ITEM ENTRY
Title American journal of clinical oncology
Related parts vol. 13
-- no. 3
-- p. 204-7
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/00000421-199006000-00005">https://doi.org/10.1097/00000421-199006000-00005</a>
Public note Available from publisher's website

No items available.